Dataset Information


MiR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer.

ABSTRACT: Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-associated death in women worldwide. microRNAs (miRNAs) play critical roles in the cellular processes of breast cancer. However, the crucial roles and underlying mechanisms of miR-539 in breast cancer remain unclear. By RT-qPCR, we found that expression of miR-539 was markedly down-regulated in breast cancer tissues and cell lines compared with that in paired adjacent normal tissues and normal cell lines. The low level of miR-539 expression was positively associated with lymph node metastasis. Furthermore, forced expression of miR-539 inhibited proliferation and migration of breast cancer MDA-MB-231 and MCF7 cells in vitro and suppressed tumor growth in vivo. Moreover, bioinformatics analysis and luciferase reporter assays indicated that epidermal growth factor receptor (EGFR) was a direct target of miR-539. Over-expression of miR-539 decreased the EGFR mRNA and protein levels in MDA-MB-231 and MCF7 cells. In addition, ectopic over-expression of EGFR partly reversed miR-539-inhibited proliferation as well as migration of MDA-MB-231 and MCF7 cells. Taken together, our results demonstrate that miR-539 functions as a tumor suppressor in breast cancer by downregulating EGFR, supporting the targeting of the novel miR-539/EGFR axis as a potentially effective therapeutic approach for breast cancer.

PROVIDER: S-EPMC5794864 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4939137 | BioStudies
| S-EPMC5656623 | BioStudies
| S-EPMC7757091 | BioStudies
2016-01-01 | S-EPMC5342531 | BioStudies
| S-EPMC3981956 | BioStudies
| S-EPMC8296627 | BioStudies
| S-EPMC8696113 | BioStudies
| S-ECPF-GEOD-25162 | BioStudies
| E-GEOD-25162 | BioStudies
2015-01-01 | S-EPMC4653246 | BioStudies